IACCARINO, Guido
 Distribuzione geografica
Continente #
NA - Nord America 16.032
AS - Asia 11.234
EU - Europa 4.338
SA - Sud America 795
Continente sconosciuto - Info sul continente non disponibili 469
AF - Africa 130
OC - Oceania 5
Totale 33.003
Nazione #
US - Stati Uniti d'America 15.735
HK - Hong Kong 6.520
SG - Singapore 2.060
IT - Italia 1.717
CN - Cina 1.007
VN - Vietnam 721
UA - Ucraina 713
BR - Brasile 629
RU - Federazione Russa 403
DE - Germania 390
TR - Turchia 248
IE - Irlanda 230
FR - Francia 214
FI - Finlandia 183
KR - Corea 182
SE - Svezia 181
CA - Canada 128
GB - Regno Unito 114
IN - India 108
BD - Bangladesh 100
AR - Argentina 60
MX - Messico 55
JP - Giappone 44
PL - Polonia 38
NL - Olanda 36
IQ - Iraq 33
ZA - Sudafrica 33
ES - Italia 31
JM - Giamaica 30
EC - Ecuador 27
PK - Pakistan 27
ID - Indonesia 23
CR - Costa Rica 22
VE - Venezuela 21
EU - Europa 20
UZ - Uzbekistan 19
PH - Filippine 17
AT - Austria 16
MY - Malesia 16
SA - Arabia Saudita 16
JO - Giordania 15
CO - Colombia 14
KE - Kenya 14
PY - Paraguay 14
TN - Tunisia 14
CZ - Repubblica Ceca 13
IL - Israele 13
CL - Cile 12
SC - Seychelles 11
AE - Emirati Arabi Uniti 10
AZ - Azerbaigian 10
HN - Honduras 9
MA - Marocco 9
NI - Nicaragua 9
CH - Svizzera 8
NP - Nepal 8
TT - Trinidad e Tobago 8
EG - Egitto 7
KZ - Kazakistan 7
PR - Porto Rico 7
AL - Albania 6
BO - Bolivia 6
PE - Perù 6
SV - El Salvador 6
BH - Bahrain 5
DO - Repubblica Dominicana 5
DZ - Algeria 5
EE - Estonia 5
ET - Etiopia 5
GT - Guatemala 5
KG - Kirghizistan 5
LT - Lituania 5
AO - Angola 4
BE - Belgio 4
BS - Bahamas 4
CI - Costa d'Avorio 4
GR - Grecia 4
NG - Nigeria 4
RS - Serbia 4
SN - Senegal 4
TH - Thailandia 4
AU - Australia 3
BG - Bulgaria 3
GE - Georgia 3
GH - Ghana 3
LU - Lussemburgo 3
MK - Macedonia 3
OM - Oman 3
BB - Barbados 2
BZ - Belize 2
CW - ???statistics.table.value.countryCode.CW??? 2
GY - Guiana 2
KY - Cayman, isole 2
LB - Libano 2
LV - Lettonia 2
NO - Norvegia 2
PT - Portogallo 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
SR - Suriname 2
Totale 32.524
Città #
Hong Kong 6.507
Ann Arbor 2.883
Wilmington 2.394
San Jose 1.255
Singapore 1.090
Jacksonville 893
Woodbridge 856
Chandler 846
Princeton 691
Ashburn 626
Milan 607
Houston 587
Dallas 473
Council Bluffs 425
Dong Ket 307
Dublin 230
Beijing 215
The Dalles 210
Izmir 205
Lauterbourg 185
Rome 168
Boardman 160
Nanjing 159
Andover 158
Pellezzano 138
Ho Chi Minh City 137
Mestre 135
Santa Clara 126
Moscow 124
Los Angeles 120
Dearborn 98
New York 98
Salerno 90
Hanoi 89
Munich 88
Düsseldorf 80
Fairfield 71
São Paulo 66
Changsha 56
Figino 55
Shenyang 53
Hebei 44
Memphis 43
Phoenix 43
Turin 43
Falls Church 42
Nanchang 42
Tokyo 42
Montreal 37
Orem 37
Brooklyn 36
Atlanta 35
San Francisco 34
Warsaw 33
Jiaxing 32
Norwalk 32
Saint Petersburg 32
Napoli 31
San Diego 29
Naples 27
London 26
Denver 25
Mexico City 25
Turku 25
Tianjin 24
Chennai 23
Chicago 23
Rio de Janeiro 23
Venezia 23
Buffalo 22
Johannesburg 22
Washington 22
Columbus 21
Frankfurt am Main 20
Manchester 20
Nuremberg 20
Philadelphia 20
Stockholm 20
Charlotte 19
Toronto 19
Jinan 18
Grevenbroich 17
Redwood City 17
Tashkent 17
Da Nang 16
Haiphong 16
Newark 16
Seattle 16
Cambridge 15
Guangzhou 15
Pune 15
Shanghai 14
Brasília 13
Kingston 13
Poplar 13
San José 13
Seoul 13
Amman 12
Amsterdam 12
Baghdad 12
Totale 25.183
Nome #
Difficult-to-control hypertension: identification of clinical predictors and use of ICT-based integrated care to facilitate blood pressure control 904
Serum uric acid predicts heart failure in a large Italian cohort: search for a cut-off value the URic acid Right for heArt Health study 871
Physical activity ameliorates cardiovascular health in elderly subjects: the functional role of the Beta adrenergic system. 581
G protein-coupled receptor kinase 2 in patients with acute myocardial infarction. 543
Insulin-induced changes in beta-adrenergic response: an experimental study in the isolated rat papillary muscle. 516
"Freeze, Don't Move": How to Arrest a Suspect in Heart Failure - A Review on Available GRK2 Inhibitors 446
Hyperuricemia and Risk of Cardiovascular Outcomes: The Experience of the URRAH (Uric Acid Right for Heart Health) Project 445
Mitochondrial Localization Unveils a Novel Role for Grk2 in the Regulation of Oxidative Metabolism 348
The Italian version of the quick mild cognitive impairment (Qmci-I) screen: normative study on 307 healthy subjects 323
Lymphocyte G-protein-coupled receptor kinase-2 is upregulated in patients with Alzheimer's disease. 316
SAR study and conformational analysis of a series of novel peptide G protein-coupled receptor kinase 2 inhibitors 316
Adrenergic signaling in heart failure and cardiovascular aging 308
Integrated care pathways for airway diseases (AIRWAYS-ICPs) 291
G-protein-coupled receptor kinase 2 and hypertension: molecular insights and pathophysiological mechanisms. 284
Progression from hypertrophic to dilated cardiomyopathy in mice that express a mutant myosin transgene. 267
Towards a re-definition of 'cardiac hypertrophy' through a rational characterization of left ventricular phenotypes: a position paper of the Working Group 'Myocardial Function' of the ESC. 267
Serum uric acid and left ventricular mass in essential hypertension 265
Cardiac betaARK1 upregulation induced by chronic salt deprivation in rats. 263
The G-protein-coupled receptor kinase 5 inhibits NFkappaB transcriptional activity by inducing nuclear accumulation of IkappaB alpha. 258
Thyroid function predicts increased cardiovascular risk 245
Characterization of a selective CaMKII peptide inhibitor 238
Vitamin D, parathyroid hormone and cardiovascular risk: The good, the bad and the ugly 232
Cellular subtype expression and activation of CaMKII regulate the fate of atherosclerotic plaque 228
Myocardial overexpression of GRK3 in transgenic mice: evidence for in vivo selectivity of GRKs. 227
Targeting the CaMKII/ERK Interaction in the Heart Prevents Cardiac Hypertrophy 222
Enhanced GRK2 expression and desensitization of betaAR vasodilatation in hypertensive patients. 217
To NFκB or not to NFκB: The Dilemma on How to Inhibit a Cancer Cell Fate Regulator 217
A Novel CaMKII/ERK Interaction n the Heart Sustains Cardiac Hypertrophy in Spontaneously Hypertensive Rats 216
A novel crosstalk between calcium/calmodulin kinases II and IV regulates cell proliferation in myeloid leukemia cells 214
A new synthetic protein, TAT-RH, inhibits tumor growth through the regulation of NFkappaB activity. 213
AKT participates in endothelial dysfunction in hypertension. 206
Influence of digitalis on left ventricular functional response to exercise in congestive heart failure. 204
Expression of a β-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted mice 202
L41Q polymorphism of the G protein coupled receptor kinase 5 is associated with left ventricular apical ballooning syndrome. 201
Age-Related Impairment in Insulin Release: The Essential Role of β2-Adrenergic Receptor. 195
Beta2-adrenergic receptor polymorphisms and treatment-induced regression of left ventricular hypertrophy in hypertension. 194
Elevated myocardial and lymphocyte GRK2 expression and activity in human heart failure. 194
Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice. 186
G protein-coupled receptor kinase 2 activity impairs cardiac glucose uptake and promotes insulin resistance after myocardial ischemia. 179
Inflammatory mediators in a short-time mouse model of doxorubicin-induced cardiotoxicity 179
Targeting myocardial remodelling to develop novel therapies for heart failure 178
Cardiotoxic effects of short-term doxorubicin administration: Involvement of connexin 43 in calcium impairment 178
Abnormal sympathetic overactivity evoked by insulin in the skeletal muscle of patients with essential hypertension. 177
GRK2 endothelial deletion causes hypotension and defective vasoconstriction in Tie2-CRE/GRK2fl/fl transgenic mice 177
Mitochondrial localization unveils a novel role for GRK2 in organelle biogenesis 175
Operational Definition of Active and Healthy Aging (AHA): The European Innovation Partnership (EIP) on AHA Reference Site Questionnaire: Montpellier October 20-21, 2014, Lisbon July 2, 2015 175
Acute noradrenergic activation induces insulin resistance in human skeletal muscle 173
Insulin modulation of vascular reactivity is already impaired in prehypertensive spontaneously hypertensive rats. 173
AIRWAYS-ICPs (European Innovation Partnership on Active and Healthy Ageing) from concept to implementation 172
A novel CaMKII/ERK interaction in the heart sustains cardiac hypertrophy in spontaneously hypertensive rats 171
The Glu27 allele of the beta2 adrenergic receptor increases the risk of cardiac hypertrophy in hypertension. 170
Association Study on Long-Living Individuals from Southern Italy Identifies rs10491334 in the CAMKIV Gene That Regulates Survival Proteins. 170
Active and Healthy Ageing and Independent Living 169
Mitochondrial G protein coupled receptor kinase 2 regulates proinflammatory responses in macrophages. 168
The G protein coupled receptor kinase 2 plays an essential role in beta-adrenergic receptor-induced insulin resistance. 168
A POLYMORPHISM WITHIN THE PROMOTER OF THE DOPAMINE RECEPTOR D1 (DRD1-48A/G) ASSOCIATES WITH IMPAIRED KIDNEY FUNCTION IN WHITE HYPERTENSIVE PATIENTS 167
ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle 167
Transgenic mice targeting the heart unveil G protein-coupled receptor kinases as therapeutic targets. 167
Alterations in cardiac adrenergic signaling and calcium cycling differentially affect the progression of cardiomyopathy. 166
Design, synthesis and efficacy of novel G protein-coupled receptor kinase 2 inhibitors 166
Active and Healthy Ageing and Independent Living 2016 166
Prior exercise improves age-dependent vascular endothelial growth factor downregulation and angiogenesis responses to hind-limb ischemia in old rats 165
G beta gamma-mediated signaling: new therapeutic target for proliferative vascular disease. 165
Adenoviral gene transfer of Akt enhances myocardial contractility and intracellular calcium handling. 164
Intracardiac injection of AdGRK5-NT reduces left ventricular hypertrophy by inhibiting NF-kappaB-dependent hypertrophic gene expression. 163
CaMK4 Gene Deletion Induces Hypertension 160
Microwave-Assisted Synthesis of KN-93, a Potent and Selective Inhibitor of Ca2+/Calmoduline-Dependent Protein Kinase II 159
β2-Adrenergic receptor stimulation improves endothelial progenitor cell-mediated ischemic neoangiogenesis 159
The use of a telematic connection for the follow-up of hypertensive patients improves the cardiovascular prognosis 158
Insulin modulation of an endothelial nitric oxide component present in the alpha2- and beta-adrenergic responses in human forearm. 156
[Non-hemodynamic mechanisms of cardiovascular risk in the hypertensive patient: insulin resistance]. 155
ADRENERGIC MECHANISM IN THE CONTROL OF ENDOTHELIAL FUNCTION 153
Targeting the receptor-Gq interface to inhibit in vivo pressure overload myocardial hypertrophy. 153
Redesigning service delivery for hypertensive patients: a methodological guideline to improve the management of chronic diseases 152
Adenoviral-mediated inhibition of Gβγ signaling limits the hyperplastic response in experimental vein grafts 152
Predictive value of TG/HDL-C and GFR-adjusted uric acid levels on cardiovascular mortality: the URRAH study 151
Endothelial beta2 adrenergic signaling to AKT: role of Gi and SRC. 151
Endothelial g protein-coupled receptor kinase 2 regulates vascular homeostasis through the control of free radical oxygen species. 150
Myocardial G protein-coupled receptor kinases: implications for heart failure therapy. 148
The GPIIIA PlA2 polymorphism is associated with an increased risk of cardiovascular adverse events. 148
Human Glioblastoma Multiforme: p53 Reactivation by a Novel MDM2 Inhibitor 147
New Insights in Cardiac Calcium Handling and Excitation-Contraction Coupling 147
The crosstalk between insulin and the sympathetic nervous system: possible implications in the pathogenesis of essential hypertension. 146
Good at Heart: Preserving Cardiac Metabolism during aging 146
External support modulates G protein expression and receptor coupling in experimental vein grafts. 145
Insulin reduces reflex forearm sympathetic vasoconstriction in healthy humans. 145
CaMKII protects MKP-1 from proteasome degradation in endothelial cells. 145
Insufficient control of blood pressure and incident diabetes. 143
GRK2 at the control shaft of cellular metabolism 143
G Protein-Coupled Receptor Kinases and Hypertension 143
P501 * GRK2 inhibition with small peptide improves cardiac function during heart failure 143
Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis – A EUFOREA-ARIA-EPOS-AIRWAYS ICP statement 143
Effects of tissue factor induced by oxygen free radicals on coronary flow during reperfusion. 143
Atrial fibrillation and microRNAs 143
CHRONIC HEART FAILURE IN THE ELDERLY: STAGES IN THE EVOLUTION OF CHRONIC HEART FAILURE; THE ENDOTHELIAL BORDER; 142
Endothelial alpha1-adrenoceptors regulate neo-angiogenesis. 141
Enhanced Expression of ss3-Adrenoceptors in Cardiac Myocytes Attenuates Neurohormone-Induced Hypertrophic Remodeling through Nitric Oxide Synthase. 141
The mechanisms of air pollution and particulate matter in cardiovascular diseases 141
Operational definition of Active and Healthy Ageing (AHA): A conceptual framework 141
GRK2 Levels in Umbilical Arteries of Pregnancies Complicated by Gestational Hypertension and Preeclampsia. 140
Totale 21.644
Categoria #
all - tutte 99.549
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 99.549


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.217 0 0 0 0 62 45 16 60 183 167 150 534
2022/20231.960 209 124 28 231 282 415 8 207 312 2 101 41
2023/2024728 99 105 33 36 42 67 26 44 13 55 26 182
2024/20252.001 82 28 18 68 91 310 248 214 330 131 235 246
2025/202613.908 1.316 3.436 2.799 475 955 551 1.471 316 505 822 266 996
2026/20272.313 314 272 717 824 186 0 0 0 0 0 0 0
Totale 33.003